Showing results (221-230 of 242) with videos related to

Sort By:
Pageof 25
Clinical Epigenetics|May 14, 2020
Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosisJee Yeon Kim, Bong-Geun Choi, Jaroslav Jelinek, et al.
The Lancet. Haematology|May 8, 2019
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trialGuillermo Garcia-Manero, Gail Roboz, Katherine Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylateHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Plos One|November 1, 2023
Postmortem toxicology findings from the Camden Opioid Research InitiativeDara M Kusic, Jessica Heil, Stefan Zajic, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasisAlexander E Kudinov, Alexander Deneka, Anna S Nikonova, et al.
Cancer|December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaGail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Cancer Research|January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in CancerNoël J-M Raynal, Justin T Lee, Youjun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinomaYutaka Suehiro, Chi Wai Wong, Lucian R Chirieac, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up resultsHagop M Kantarjian, Moshe Talpaz, Susan O'Brien, et al.
The Lancet. Oncology|August 29, 2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialHagop M Kantarjian, Gail J Roboz, Patricia L Kropf, et al.
Pageof 25